Child, Preschool

Polymorphisms of interleukin 6 in Down syndrome individuals: a case-control study.

M. F. Mattos, Uback, L., Biselli-Chicote, P. M., Biselli, J. M., Goloni-Bertollo, E. M., and Pavarino, E. C., “Polymorphisms of interleukin 6 in Down syndrome individuals: a case-control study.”, Genet Mol Res, vol. 16, no. 3, 2017.

Haplotypes and polymorphism in the CCR5 gene in sickle cell disease.

A. F. Nascimento, Oliveira, J. S., Junior, J. C. Silva, and Barbosa, A. A. L., “Haplotypes and polymorphism in the CCR5 gene in sickle cell disease.”, Genet Mol Res, vol. 16, no. 2, 2017.

Determination of SCN1A genetic variants in Mexican patients with refractory epilepsy and Dravet syndrome.

R. E. Jiménez-Arredondo, Brambila-Tapia, A. J. L., Mercado-Silva, F. M., Magaña-Torres, M. T., and Figuera, L. E., “Determination of SCN1A genetic variants in Mexican patients with refractory epilepsy and Dravet syndrome.”, Genet Mol Res, vol. 16, no. 2, 2017.

MNS, Duffy, and Kell blood groups among the Uygur population of Xinjiang, China.

G. Y. Lin, Du, X. L., Shan, J. J., Zhang, Y. N., Zhang, Y. Q., and Wang, Q. H., “MNS, Duffy, and Kell blood groups among the Uygur population of Xinjiang, China.”, Genet Mol Res, vol. 16, no. 1, 2017.

Inhibition of SHH pathway mechanisms by arsenic trioxide in pediatric medulloblastomas: a comprehensive literature review.

P. H. S. Klinger, Andrade, A. F., Delsin, L. E. A., Queiroz, R. G. P., Scrideli, C. A., Tone, L. G., and Valera, E. T., “Inhibition of SHH pathway mechanisms by arsenic trioxide in pediatric medulloblastomas: a comprehensive literature review.”, Genet Mol Res, vol. 16, no. 1, 2017.